Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Where to spend the money ??

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154867
(Total Views: 547)
Posted On: 01/20/2020 12:31:47 PM
Avatar
Posted By: TechGuru
I hope NP finalizes the financing deal and this money will be very wisely used .

The priorities for where to spend the monies are clear (no surprises but needs to be done):

1) We need to launch the pivotal trial on Monotheraphy. The results already obtained are excellent and we need to cross the line and launch Leronlimab as Mono. The funds should be there to start as soon as possible (pending FDA green-light) with this. Once in the market we will start getting a much-needed revenue.

2) We need to further trials in NASH . Already Cencriviroc (Takeda a dual CCR2-CCR5 inhibitor) and Tropifexor (FXR agonist Novartis+Pfizer) are being evaluated in phase III. Maraviroc ( (Pfizer) CCR5, small molecule antagonist) also was successful in a murine model. However, Leronlimab seems to be vastly superior to all of these. The idea here is that the further we advance the results the more superior Lero will be and the higher the price anybody will have to pay for it. The approach that Pfizer is taking is to go for a combination approach https://seekingalpha.com/article/4215823-pfiz...n-approach What Lero has done ALONE is amazing but we need to explore partnerships once it is determine it is good on its own.

3) We need to further our Oncology indications. mTNBC is certainly a good start but the field out there is large and unexplored. Having a superior CCR5 antagonist really opens a large amount of doors. Maraviroc and Vicrivoc are already being tested with Keytruda (pembrolizumab), one of top-selling drugs ($7.1B) !!! The more effective and less secondary effects of Lero would beat hands-down these small molecule agonists (by the way, Pembrolizumab is also a humanized antibody).

We need to start trying Lero with Keytruda or with Opdivo or Yervoy or others, in different indications. This will give us the piggy-tail we need to enter the stage with a big bang !!!; we are talking BP pharma here, and maybe (therapeutically-speaking) they will be piggy-tailing on us, not the other way around.

So, we need funds to continue progressing and making our Lero more valuable. Also, we need to increase the speed of our research . Sometimes it is not who is better, but, who gets there first. Let’s secure the funding and accelerate the human or otherwise trials to show the real worth of Leronlimab (clinically and economically.)


(9)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us